{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
APT Medical, Inc.
APT Medical Hits Day Low at CNY 231.46 Amid Price Pressure
APT Medical, Inc. saw a decline in stock performance, contrasting with the broader market trends. Over the past year, the company has underperformed compared to the China Shanghai Composite. However, it has demonstrated resilience with significant returns over three and five years, maintaining a high market capitalization and price-to-earnings ratio.
APT Medical Hits Day High with 8.24% Surge, Defying Market Trends
APT Medical, Inc. saw a notable increase in its stock performance on February 27, 2026, reaching an intraday high. The company has demonstrated resilience amid a declining market, with recent weekly and monthly gains. However, its long-term performance lags behind the broader market, and its valuation remains elevated.
APT Medical Hits Day High with 4.21% Surge, Outperforming Market
APT Medical, Inc. has demonstrated strong financial performance, with net sales increasing by 21.99% in the first nine months. The company has outperformed the China Shanghai Composite in both weekly and monthly metrics, boasting a market capitalization of CNY 42,445 million and a return on equity of 26.46%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
